Loading…
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 46 other SJRES bills in the 110th — cohort avg 40d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2008 · fourth_quarter · Medicare/Medicaid
S. 59/H.R. 2066 - To amend title XIX of the Social Security Act to improve access to advanced practice nurses and physician assistants under the Medicaid Program; H.R. 5585 - To amend title XVIII of the Social Security Act to provide comprehensive cancer patient treatment education under the Medicare Program and to provide for research to improve cancer symptom management; H.R. 1078/S. 2790 - To amend title XVIII of the Social Security Act to provide for coverage of comprehensive cancer care planning under the Medicare Program and to improve the care furnished to individuals diagnosed with cancer by establishing a Medicare hospice care demonstration program and grants programs for cancer palliative care and symptom management programs, provider education, and related research; H.R. 6826/S. 1678 - To amend title XVIII of the Social Security Act to ensure more timely access to home health services for Medicare beneficiaries under the Medicare Program; S. J. Res. 22/H.J. Res. 54 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; H.R. 6725 - To establish budget neutral demonstration projects to study and improve the quality and cost effectiveness of cancer care services provided to Medicare beneficiaries; Comprehensive Cancer Omnibus Legislation.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2008 · third_quarter · Health Issues
S. 465- Advance Directives Improvement and Education Act of 2007 ; S. 459/H.R. 758 - Breast Cancer Patient Protection Act of 2007 ; S. 358/H.R. 493 - Genetic Information Nondiscrimination Act of 2007; S. 446/H.R. 772 - Nurse Education, Expansion, and Development Act of 2007 ; S. 1604 - Nursing Education and Quality of Health Care Act of 2007 ; H.R. 2384 - Nurse Faculty Higher Education Act; H.R. 2621 - Teacher and Nurse Support Act of 2007; S. 646 - Rural Nursing Promotion Act; (Continued Next Page) S. 1056 - National Cancer Act of 2007; S. 624/H.R. 1132 - National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007; S. 73/H.R. 4138 - Registered Nurse Safe Staffing Act of 2007; S. 2999/H.R. 2676 - Access to Cancer Clinical Trials Act of 2008; S. J. Res. 22/H.J. Res. 54 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; S. 2140 - To award a Congressional Gold Medal to Francis Collins, in recognition of his outstanding contributions and leadership in the fields of medicine and genetics; H.R. 6791- National Cancer Fund Act of 2008
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2008 · first_quarter · Medicare/Medicaid
H.J. Res. 54/S.J. Res. 22 Medicare payment, policy issues relating to physician payments, chemotherapy, imaging, radiation therapy, including provisions in: H.R. 3162, the Children's Health and Medicare Protection Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Medicare/Medicaid
Coverage and reimbursement of erythropoiesis-stimulating agent (ESA products) = SJ RES.22.
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Medicare/Medicaid
HJRes 54, SJRes 22 - provision in its entirety HR 3162- CHAMP Act - provisions relating to Erythropoiesis-Stimulating Agents (ESA) coverage Medicare Coverage and Reimbursement of ESAs
Client expense: Not reported · Firm income: $120,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Medicare/Medicaid
S. J. Res. 22, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions;
Client expense: Not reported · Firm income: $90,000
Government targets: SENATE
2007 · year_end · Medicare/Medicaid
H.J. Res. 54/S.J. Res. 22 Medicare payment, policy issues relating to physician payments, chemotherapy, imaging, radiation therapy, including provisions in: H.R. 3162, the Children's Health and Medicare Protection Act of 2007 S. 2499, the Medicare, Medicaid, and SCHIP Extension Act of 2007
Client expense: Not reported · Firm income: $80,000
| Republican |
| NE |
| Dianne Feinstein | Democratic | CA |
| Elizabeth Dole | Republican | NC |
| Evan Bayh | Democratic | IN |
| James M. Inhofe | Republican | OK |
| Jim Webb | Democratic | VA |
| Johnny Isakson | Republican | GA |
| Jon Tester | Democratic | MT |
| Joseph Biden | Democratic | DE |
| Joseph I. Lieberman | Independent | CT |
| Kay Bailey Hutchison | Republican | TX |
| Ken Salazar | Democratic | CO |
| Lamar Alexander | Republican | TN |
| Lindsey Graham | Republican | SC |
| Maria Cantwell | Democratic | WA |
| Mel Martinez | Republican | FL |
| Mike Crapo | Republican | ID |
| Pat Roberts | Republican | KS |
| Patty Murray | Democratic | WA |
| Richard Burr | Republican | NC |
| Richard J. Durbin | Democratic | IL |
| Robert Bennett | Republican | UT |
| Robert P. Casey, Jr. | Democratic | PA |
| Ron Wyden | Democratic | OR |
| Susan M. Collins | Republican | ME |
| Tom Coburn | Republican | OK |
| Trent Lott | Republican | MS |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE